Intervention

protein expression analysis

ClinicalTrials.gov intervention label

Clinical trials38
Recruiting1
Common conditions25
Lead sponsors shown15

Clinical trials

38 shown
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung CancerNCT00897117 · 2001-05-01
RECRUITING
Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With BevacizumabNCT01156168 · 2011-04-05
COMPLETED
Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer SurvivorsNCT01196936 · 2010-09-01
ACTIVE_NOT_RECRUITING
Vorinostat in Treating Women With Ductal Carcinoma in Situ of the BreastNCT00788112 · 2009-07-01
COMPLETED
PTC299 in Treating Patients With HIV-Related Kaposi SarcomaNCT00686842 · 2008-09-01
TERMINATED
Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to ChemotherapyNCT00801385 · 2008-09-01
UNKNOWN
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerNCT00729612 · 2008-08-14
COMPLETED
Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803NCT00897351 · 2008-07-10
COMPLETED
Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast CancerNCT00674557 · 2008-06-01
TERMINATED
Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian CancerNCT00664781 · 2007-12-01
COMPLETED
Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung CancerNCT00499655 · 2007-11-01
COMPLETED
Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerNCT00550537 · 2007-10-01
COMPLETED
Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryNCT00589056 · 2007-06-01
COMPLETED
Genetics of Women With Lobular Carcinoma in Situ of the BreastNCT00536718 · 2007-06-01
UNKNOWN
Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast CancerNCT00899197 · 2007-05-01
TERMINATED
Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or VermiculiteNCT00897247 · 2007-01-01
COMPLETED
Tumor Response to Pemetrexed Disodium in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Enrolled in Clinical Trial MCCRC-RC0524NCT00898820 · 2006-11-01
COMPLETED
Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous TreatmentNCT00673569 · 2006-09-01
COMPLETED
S9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313NCT00896727 · 2006-07-17
COMPLETED
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17NCT00897065 · 2006-06-01
UNKNOWN
Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)NCT00499083 · 2006-05-01
COMPLETED
Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyNCT00524589 · 2006-04-01
TERMINATED
Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With ChemotherapyNCT00897299 · 2005-10-07
COMPLETED
ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous TreatmentNCT00425672 · 2005-09-01
COMPLETED
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerNCT00900302 · 2005-04-01
COMPLETED
Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsNCT00389805 · 2005-03-01
COMPLETED
Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by SurgeryNCT00665457 · 2004-04-15
TERMINATED
Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast CancerNCT00896857 · 2004-04-01
COMPLETED
Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast CancerNCT00343512 · 2004-02-01
TERMINATED
Nipple Aspiration, Ductal Lavage, and Duct Endoscopy in Screening Women at Moderate-to-High Risk of Developing Breast CancerNCT00081003 · 2003-11-01
COMPLETED
Serum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE)NCT00898209 · 2003-04-01
TERMINATED
Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyNCT00176527 · 2002-11-01
TERMINATED
Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by SurgeryNCT00633750 · 2002-08-01
COMPLETED
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian CancerNCT00436254 · 2001-10-01
COMPLETED
Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast DiseaseNCT00813878 · 2001-07-01
TERMINATED
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy ParticipantsNCT00899028 · 2001-05-01
COMPLETED
UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With CancerNCT00900094 · 2000-06-01
COMPLETED
Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154NCT00535834
COMPLETED

Trial status mix

COMPLETED24
TERMINATED9
UNKNOWN3
ACTIVE_NOT_RECRUITING1
RECRUITING1

Phase mix

PHASE218
PHASE16
NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.